Novo Nordisk to Invest $4.1 Billion in New Facility in North Carolina

Novo Nordisk plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, N.C., as demand for weight-loss drugs show no signs of letting up.